Design working on therapy targeting toxic Huntington’s protein

Design working on therapy targeting toxic Huntington’s protein

Small molecules developed by Design Therapeutics were able to reduce the activity of the disease-causing mutant gene in preclinical models of Huntington’s disease, according to an announcement from the company. “We are highlighting an exciting new program for Huntington’s Disease, an indication of tremendous unmet medical need,”…

The importance of uniting and prioritizing healthcare for all

I’ve come to a realization that has impacted my viewpoint about the importance of voting and advocating for political candidates who prioritize healthcare. It was prompted by my wife Jill’s diagnosis of Huntington’s disease (HD) and the challenges we’ve faced navigating the healthcare system as we deal with…

2 small molecules ease symptoms, progression in mice, study finds

Two types of orally available small molecules ameliorated symptoms and slowed progression of Huntington’s disease in a mouse model, a study reported. The treatments effectively reduced the levels of the mutant huntingtin protein in the brain without affecting normal huntingtin. The mutant version causes Huntington’s, a neurodegenerative condition.